Literature DB >> 23433789

Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria.

I Puxeddu1, P Italiani, P Giungato, F Pratesi, F Panza, D Bartaloni, V Rocchi, I Del Corso, D Boraschi, P Migliorini.   

Abstract

Overproduction of IL-18 has been described in chronic urticaria. To evaluate free IL-18 and IL-33 in chronic spontaneous urticaria (CSU). IL-18, its inhibitor IL-18BP, IL-33 and its soluble receptor ST2 (sST2) were measured (ELISA) in the sera of 73 CSU patients. Free IL-18 was calculated (law of mass action). Autologous serum skin test (ASST) was performed in all patients. Total IL-18, IL-18BP and free IL-18 serum levels were significantly higher in CSU than in controls. IL-18 and IL-18BP increased significantly in both ASST-positive and negative subgroups. Free IL-18 resulted significantly higher in the ASST-negative, but not in the ASST-positive subgroup. No differences in IL-33/sST2 levels were detected between CSU and controls. Increased levels of free IL-18 and IL-18BP, but not IL-33, was detected in CSU. Whether IL-18 up-regulation is a consequence of inflammation or one of the causes of the pathology needs to be addressed.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433789     DOI: 10.1016/j.cyto.2013.01.015

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  17 in total

1.  Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation.

Authors:  Adnan K Syed; Tamra J Reed; Kaitlyn L Clark; Blaise R Boles; J Michelle Kahlenberg
Journal:  Infect Immun       Date:  2015-06-15       Impact factor: 3.441

Review 2.  IL-18 and Cutaneous Inflammatory Diseases.

Authors:  Ji Hyun Lee; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2015-12-09       Impact factor: 5.923

3.  The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria.

Authors:  Tao Lu; Xiaoyang Jiao; Mengya Si; Ping He; Jinbo Zou; Shuping Zhang; Kang Zeng
Journal:  Dis Markers       Date:  2016-01-12       Impact factor: 3.434

4.  Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria.

Authors:  Wei Lin; Qiongyan Zhou; Chunbo Liu; Mengxia Ying; Suling Xu
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 5.  Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?

Authors:  Ilaria Puxeddu; Federico Pratesi; Domenico Ribatti; Paola Migliorini
Journal:  Mediators Inflamm       Date:  2017-09-05       Impact factor: 4.711

6.  Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Authors:  Ilaria Puxeddu; Fiorella Petrelli; Francesca Angelotti; Cristina Croia; Paola Migliorini
Journal:  J Asthma Allergy       Date:  2019-09-20

7.  Interleukin 1-β, interleukin-1 receptor antagonist, and interleukin 18 in children with acute spontaneous urticaria.

Authors:  E Machura; M Szczepańska; B Mazur; M Barć-Czarnecka; A Kasperska-Zając
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

8.  Elevated Plasma Level of Interferon-λ1 in Chronic Spontaneous Urticaria: Upregulated Expression in CD8(+) and Epithelial Cells and Induction of Inflammatory Cell Accumulation.

Authors:  S F Wang; X Q Gao; Y N Xu; D N Li; H Y Wang; S H He
Journal:  Mediators Inflamm       Date:  2016-06-30       Impact factor: 4.711

Review 9.  Roles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin Diseases.

Authors:  Youn Kyung Houh; Kyung Eun Kim; Hyun Jeong Park; Daeho Cho
Journal:  Int J Mol Sci       Date:  2016-12-08       Impact factor: 5.923

10.  Altered Gut Microbiota Diversity and Composition in Chronic Urticaria.

Authors:  Tao Lu; Yanxia Chen; Yangmin Guo; Jiayu Sun; Weitao Shen; Mengsi Yuan; Shuping Zhang; Ping He; Xiaoyang Jiao
Journal:  Dis Markers       Date:  2019-11-11       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.